[HTML][HTML] A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer …
…, CR Lewis, S Varma, A Broad, N Muljadi, S Chinchen… - Annals of …, 2015 - Elsevier
Background We sought to determine whether the substantial benefits of topical nitroglycerin
with first-line, platinum-based, doublet chemotherapy in advanced nonsmall-cell lung …
with first-line, platinum-based, doublet chemotherapy in advanced nonsmall-cell lung …
A signal-seeking phase II trial of durvalumab and tremelimumab focused on advanced, rare and less common cancers
…, P Craft, R Cosman, C Lee, K Harwood, S Chinchen… - medRxiv, 2022 - medrxiv.org
Immune checkpoint blockade impedes the negative regulatory signals for T-cell response
and permits more effective immune detection and eradication of cancer cells. This single-arm …
and permits more effective immune detection and eradication of cancer cells. This single-arm …
Interactions between subtotal nephrectomy and salt: effects on blood pressure and renal function in pregnant and nonpregnant ewes
…, AC Boyce, CL Thomson, S Chinchen… - American Journal …, 2008 - journals.physiology.org
The effects of high salt intake on blood pressure and renal function were studied in nine
subtotally nephrectomized pregnant ewes (STNxP) and seven intact pregnant ewes (IntP) in late …
subtotally nephrectomized pregnant ewes (STNxP) and seven intact pregnant ewes (IntP) in late …
Trastuzumab emtansine (T-DM1) in advanced cancers with HER2 mutations or amplification: Results from the Molecular Screening and Therapeutics (MoST) …
…, RA Harrup, A Nagrial, L Sebastian, S Chinchen… - 2023 - ascopubs.org
3127 Background: The antibody-drug conjugate T-DM1 is widely used for the treatment of
HER2-positive metastatic breast cancer. Its activity in other advanced solid tumors harboring …
HER2-positive metastatic breast cancer. Its activity in other advanced solid tumors harboring …
A signal-seeking trial of olaparib and durvalumab in homologous repair-deficient tumors: A sub-study of the cancer molecular screening and therapeutics (MoST) …
…, L Sebastian, ML Ballinger, W Hague, S Chinchen… - 2020 - ascopubs.org
3073 Background: Data on the utility of a PARP inhibitor in combination with a checkpoint
inhibitor remain limited, particularly in the histology agnostic setting with homologous …
inhibitor remain limited, particularly in the histology agnostic setting with homologous …
NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy (SABR) in advanced non-small cell lung cancer (NSCLC) …
…, A Mersiades, K O'Byrne, S Chinchen… - Asia-Pacific Journal …, 2018 - eprints.qut.edu.au
Background: Recent data has demonstrated improvements in overall survival in patients
with NSCLC treated with nivolumab. Radiation may augment the immune response through …
with NSCLC treated with nivolumab. Radiation may augment the immune response through …
[BOOK][B] A surfactantless emulsion as a model for the liquid-liquid interface
KM Knight - 2006 - search.proquest.com
… I would also like to thank Sarah Robbie, Julia Tomlinson, Sarah Chinchen and Annabel
Rein for being such fantastic friends and always being there for me. …
Rein for being such fantastic friends and always being there for me. …
[HTML][HTML] Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy–results from the randomised …
…, L Benito, K Lopez, A Hernández, S Chinchen… - Annals of …, 2022 - Elsevier
Background Concurrent chemotherapy and thoracic radiotherapy followed by prophylactic
cranial irradiation (PCI) is the standard treatment in limited-disease small-cell lung cancer (LD…
cranial irradiation (PCI) is the standard treatment in limited-disease small-cell lung cancer (LD…
Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly
VA Schneider, T Graves-Lindsay, K Howe… - Genome …, 2017 - genome.cshlp.org
The human reference genome assembly plays a central role in nearly all aspects of today's
basic and clinical research. GRCh38 is the first coordinate-changing assembly update since …
basic and clinical research. GRCh38 is the first coordinate-changing assembly update since …
The complete sequence of a human Y chromosome
The human Y chromosome has been notoriously difficult to sequence and assemble
because of its complex repeat structure that includes long palindromes, tandem repeats and …
because of its complex repeat structure that includes long palindromes, tandem repeats and …